Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
109
NCT02965170
Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS
Phase: N/A
Role: Collaborator
Start: Oct 31, 2016
Completion: May 31, 2018